Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Neurogastroenterology and Motility|June 13, 2014
Markers for visceral hypersensitivity in patients with irritable bowel syndromeS Ludidi, Z Mujagic, D Jonkers, et al.
Neurogastroenterology and Motility|July 26, 2024
Do antro-duodenal manometry parameters predict clinical response after gastric peroral endoscopic pyloromyotomy in refractory gastroparesis?K W E Sweerts, Z Mujagic, J W A Straathof, et al.
Alimentary Pharmacology & Therapeutics|August 21, 2015
Systematic review: instruments to assess abdominal pain in irritable bowel syndromeZ Mujagic, D Keszthelyi, Q Aziz, et al.
Journal of Breath Research|December 2, 2025
Irritable bowel syndrome-specific volatile organic compounds in faecal headspace do not associate with classical symptom-based subtypesR Van Vorstenbosch, M Skawinski, D Jonkers, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2015
Alterations in serotonin metabolism in the irritable bowel syndromeA Y Thijssen, Z Mujagic, D M A E Jonkers, et al.
Neurogastroenterology and Motility|August 15, 2017
Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort studyL Vork, Z Z R M Weerts, Z Mujagic, et al.
Neurogastroenterology and Motility|July 18, 2017
Habitual diet and diet quality in Irritable Bowel Syndrome: A case-control studyE F Tigchelaar, Z Mujagic, A Zhernakova, et al.
Neurogastroenterology and Motility|June 24, 2015
The Experience Sampling Method--a new digital tool for momentary symptom assessment in IBS: an exploratory studyZ Mujagic, C Leue, L Vork, et al.
Alimentary Pharmacology & Therapeutics|May 3, 2016
Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approachA Baranska, Z Mujagic, A Smolinska, et al.
Pageof 2